Bosnia and Herzegovina vs Oman: Percentage of bloodstream infection due to methicillin-resistant
Bosnia and Herzegovina
26.5%
in 2022
Oman
28.6%
in 2022
Bosnia and Herzegovina rank
25th
Oman rank
23rd
Percentage of bloodstream infection due to methicillin-resistant over time
- Bosnia and Herzegovina
- Oman
How they compare
Oman currently reports 28.6% against 26.5% in Bosnia and Herzegovina, a difference of 2.1%.
That makes Oman's figure about 1.1 times Bosnia and Herzegovina's.
Across all 5 years both countries report, Oman has been ahead every year.
Bosnia and Herzegovina ranks 25th and Oman ranks 23rd of 50 countries.
Oman has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 21.1% | 45.5% | 24.5% | Oman |
| 2020s | 23.5% | 34.0% | 10.4% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Bosnia and Herzegovina or Oman?
- Oman, at 28.6% against 26.5% in Bosnia and Herzegovina as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Bosnia and Herzegovina and Oman?
- 2.1%, with Oman ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Oman?
- 5 years are reported by both, from 2017 to 2022.
- How do Bosnia and Herzegovina and Oman rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Bosnia and Herzegovina ranks 25th and Oman ranks 23rd of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.